Published in
The Lancet Regional Health - Western Pacific, (34), p. 100731, 2023
DOI: 10.1016/j.lanwpc.2023.100731
Links
Tools
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial
Journal article published in 2023 by
Kai Chu,
Zhao-Feng Bi,
Wei-Jin Huang 
,
Ya-Fei Li,
Li Zhang,
Chang-Lin Yang,
Han-Min Jiang,
Xia Zang,
Qi Chen,
Dong-Lin Liu,
Hong-Xing Pan,
Yue Huang,
Feng-Zhu Zheng,
Qiu-Fen Zhang,
Guang Sun
and other authors.
,
Ya-Fei Li,
Li Zhang,
Chang-Lin Yang,
Han-Min Jiang,
Xia Zang,
Qi Chen,
Dong-Lin Liu,
Hong-Xing Pan,
Yue Huang,
Feng-Zhu Zheng,
Qiu-Fen Zhang,
Guang Sun
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 